Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;145(15):1057-1062.
doi: 10.1055/a-1164-4100. Epub 2020 Jul 30.

[COVID-19: The Intensive Care Point-of-View]

[Article in German]

[COVID-19: The Intensive Care Point-of-View]

[Article in German]
Stephanie-Susanne Stecher et al. Dtsch Med Wochenschr. 2020 Jul.

Abstract

Approx. 93 % of COVID-19 infections are mild, and not all severely ill patients are transferred to the intensive care unit. But the Corona crisis implies high demands on intensive care medicine. Many treatment modalities of COVID patients are "best practice", but some aspects remain unclear at present. This article deals with diagnostics, monitoring and therapy with COVID-19 patients in intensive care units and with a suitable hygiene concepts.A hygiene concept is obligatory and must ensure - in addition to general measures - the training of employees and the hygienic discharge of material. Ideally, a cohort isolation is implemented.Monitoring of patients with COVID-19 is not different from other intensive care patients and should be adapted to the clinical situation of the individual patient. In laboratory analysis the typical abnormality of COVID-19 patients should be taken into account. In case of increasing inflammatory parameters, fungal infections should be tested.Due to the formation of aerosols, disconnection of the respiratory system must be avoided in invasive ventilation. If a disconnection from the respirator is necessary, the tube should be disconnected. After extubation, an intermittent NIV treatment for atelectase prophylaxis can be performed.

PubMed Disclaimer

Conflict of interest statement

Boris Böll hat Forschungsunterstützung, Honorare und Reisekosten von Astra Zeneca, Baxalta, Celgene, Gilead, J&J, MSD, Novartis, Roche, Miltenyi und Mundipharma erhalten. Alle anderen Autorinnen/Autoren geben an, dass kein Interessenkonflikt besteht.

LinkOut - more resources